Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Comparative Effects of Elliptical Exercises and Swiss Ball Aerobics Exercises in Post CABG Patients

5 maggio 2026 aggiornato da: Riphah International University

Comparative Effects Of Elliptical Exercises And Swiss Ball Aerobics Exercises On Functional Capacity, Heart Rate, Dyspnea , And Quality Of Life In Post CABG Patients

This randomized controlled trial will compare the effectiveness of elliptical exercise training and Swiss ball exercise therapy in post-CABG patients. A total of 32 participants will be recruited through convenient sampling and randomly allocated into two groups (16 each). Group A will receive supervised elliptical exercise training, while Group B will perform Swiss ball exercises, with sessions conducted three times per week for 6-8 weeks. Outcomes including functional exercise capacity (Six-Minute Walk Test), resting heart rate (pulse oximetry), dyspnea (Modified Borg Scale), and quality of life (SF-36) will be assessed at baseline and post-intervention. Data will be analyzed using SPSS to determine the more effective rehabilitation approach for improving recovery after CABG.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Coronary artery bypass grafting (CABG) is a widely performed surgical intervention aimed at restoring adequate myocardial perfusion in patients with severe coronary artery disease. Despite its benefits, patients often experience persistent limitations in functional capacity, elevated resting heart rate, and dyspnea, during the postoperative period. Effective rehabilitation strategies are essential to facilitate recovery and enhance quality of life in this population.

This randomized controlled trial aims to compare the effects of two rehabilitation approaches elliptical exercise training and Swiss ball exercise therapy on key clinical and psychological outcomes in post-CABG patients. Patient of post CABG will be selected by convenient sampling technique 32 Participants will be randomly assigned to either group 16 in each group. Group A will be treated by elliptical exercises and B will be treated with Swiss ball exercises and will engage in supervised exercise sessions three times a week for 6 to 8 weeks. Outcomes including functional exercise capacity (measured via the six-minute walk test), resting heart rate (pulse ox), dyspnea (Modified Borg Scale), and quality of life (SF-36) will be evaluated before and after the intervention.

Data will be analyzed using statistical package for social sciences spss. By comparing these two approaches, this research aims to determine which exercise method is more effective in improving both physical parameters and quality of life in post-CABG patients. The results could help improve rehabilitation programs and support faster, more complete recoveries for heart surgery patients.

Tipo di studio

Interventistico

Iscrizione (Stimato)

32

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Riphah International University
        • Investigatore principale:
          • Khadija Nawaz, MsPT(CPPT)

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

INCLUSION CRITERIA

  • Adult patients aged 40 to 60 years who have undergone elective or scheduled coronary artery bypass grafting (CABG) surgery.
  • Post-operative duration between 2 to 6 weeks, medically cleared to begin rehabilitation exercises.
  • Hemodynamically stable (normal vital signs, no signs of acute cardiac distress).
  • Willing and able to participate in a supervised rehabilitation program.

EXCLUSION CRITERIA

  • Patients with unstable angina, recent myocardial infarction (<2 weeks), or uncontrolled arrhythmias.
  • Patients with severe valvular heart disease or left ventricular ejection fraction <30%.
  • Individuals with neurological conditions (e.g., Parkinson's disease, stroke) that impair mobility or coordination.
  • Patients with severe musculoskeletal disorders (e.g., joint replacement, severe arthritis, recent fractures).
  • Cognitive impairment (e.g., dementia, significant memory loss) that prevents understanding or following instructions.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Group A
Group A will be recieving elliptical exercise (Steady state moderate intensity protocol on elliptical trainer, interval elliptical training)
Altro: elliptical exercises
Participants allocated to the this group will undergo a structured aerobic training program using an elliptical trainer. The exercise prescription will adhere to the FITT framework as follows: frequency of five sessions per week, moderate intensity (targeting approximately 50-70% of heart rate reserve or corresponding Rating of Perceived Exertion of 12-14 on the Borg scale), and duration of 30 minutes per session. Each session will be supervised and will include appropriate warm-up and cool-down periods according to standard cardiac rehabilitation protocols. The intervention will be delivered consistently throughout the study period using an elliptical exercise modality.
Comparatore attivo: Group B
Group B will be recieving swiss ball exercises (Seated arm raises with light weights and bands, seated torso rotation,seated bouncing,arm circles and punches while sitting,diaphragmatic breathing with ball hug, wall squat with swiss ball support).
Altro: swiss ball exercises
Participants allocated to this group will receive a structured exercise program using Swiss ball-based training. The intervention will follow the FITT principle as follows: frequency of five sessions per week, moderate intensity (corresponding to a Rating of Perceived Exertion of 12-14 on the Borg scale), and duration of 30 minutes per session. The exercise type will consist of flexibility and breathing exercises performed with the Swiss ball. Each session will be supervised and will include standardized warm-up and cool-down components in accordance with established rehabilitation protocols. The intervention will be delivered consistently throughout the study period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
functional capacity
Lasso di tempo: pretreatment, 4th week, 8th week
6-Minute Walk Test (6MWT) is a practical and widely used assessment tool to measure exercise capacity and functional status in individuals with various health conditions. To perform the test, a flat, straight corridor with a measured distance is required. The individual is instructed to walk at their own pace, aiming to cover as much distance as possible within the 6-minute time frame. They can slow down, stop, or rest if needed, but the timer continues to run. The test administrator records the total distance walked, as well as any symptoms, such as shortness of breath or fatigue. The 6MWT is a valuable tool for assessing exercise capacity improvement, as it reflects an individual's ability to perform daily activities and can be used to monitor changes in functional status over time or in response to interventions, such as exercise training or rehabilitation programs. By tracking changes in distance walked, healthcare providers can evaluate the effectiveness of treatment plan.
pretreatment, 4th week, 8th week
Heart rate
Lasso di tempo: pretreatment, 4th week, 8th week.
A pulse oximeter, often referred to as a pulse ox, is a small, non-invasive medical device that clips onto a fingertip, toe, or earlobe to measure two critical health metrics: oxygen saturation (SpO2) and heart rate. Oxygen saturation indicates the percentage of hemoglobin in the blood that is carrying oxygen, while heart rate measures the number of heart beats per minute (bpm). To use a pulse oximeter for measuring heart rate, simply place the device on the chosen site, ensuring a snug fit, and turn it on. After a few seconds, the device will display both your oxygen saturation level and heart rate. It's essential to remain still during measurement to ensure accuracy, as movement can interfere with the readings. A pulse oximeter is a valuable tool for monitoring heart rate, especially for individuals with heart conditions, respiratory issues, or those engaging in high-altitude activities. By providing quick and reliable readings, it helps users track their heart rate in real-time.
pretreatment, 4th week, 8th week.
Dyspnoea
Lasso di tempo: pretreatment, 4th week, 8th week
The Modified Borg Scale is a widely used tool to assess the severity of dyspnea (shortness of breath) in patients. It is a simple, self-reported scale that asks patients to rate the intensity of their breathlessness from 0 to 10, with 0 indicating "no breathlessness" and 10 indicating "maximal breathlessness." To use the Modified Borg Scale, patients are asked to select a number that corresponds to the severity of their dyspnea, with descriptors provided for each level of severity, such as "slight" (1-2), "moderate" (3-4), "severe" (5-6), and "very severe" (7-10). This scale helps healthcare providers quantify the impact of dyspnea on patients' daily lives and monitor changes in symptoms over time or in response to treatment. By regularly assessing dyspnea using the Modified Borg Scale, healthcare providers can tailor interventions to meet individual patient needs, evaluate the effectiveness of treatments, and improve patient outcomes.
pretreatment, 4th week, 8th week
Quality of life in post-CABG patients
Lasso di tempo: pretreatment, 4th week , 8th week
The Short Form 36 (SF-36) is a widely used, multi-dimensional health survey that measures eight domains of health status: physical functioning, bodily pain, general health, vitality, social functioning, emotional functioning, and mental health. It is a self-reported questionnaire that assesses an individual's perceived health and well-being over a specific period, typically the past four weeks. The SF-36 is used in various settings, including clinical trials, health services research, and individual patient assessments, to evaluate the impact of diseases, treatments, and interventions on quality of life. To use the SF-36, patients are asked to complete the questionnaire, which consists of 36 items. The results provide a comprehensive profile of the patient's health status, allowing healthcare providers to identify areas of strength and weakness, monitor changes over time, and make informed decisions about care. The SF-36's scores can also be used to compare the health status of differ
pretreatment, 4th week , 8th week

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Riphah International University

Investigatori

  • Investigatore principale: Wajeeha Zia, phd, Riphah International University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

10 maggio 2026

Completamento primario (Stimato)

20 agosto 2026

Completamento dello studio (Stimato)

20 agosto 2026

Date di iscrizione allo studio

Primo inviato

5 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

5 maggio 2026

Primo Inserito (Effettivo)

11 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

11 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

5 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • Khadija Nawaz

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su CABG

Prove cliniche su elliptical exercises

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Trinidad & Tobago

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

Sottoscrivi